SCHEMBL2007885

SCHEMBL2007885

OCCc1nc[nH]n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2008791 0.86
SCHEMBL17393309 0.84 LOX (0.34)
SCHEMBL16673433 0.84
SCHEMBL4684712 0.82 L3MBTL1 (0.34)
Hydrochloric Acid SCHEMBL1550504 0.82
SCHEMBL16673289 0.79 L3MBTL1 (0.37)
SCHEMBL16673303 0.79 L3MBTL1 (0.39)
SCHEMBL22986894 0.77 L3MBTL1 (0.41)
SCHEMBL11162108 0.75
Hydrochloric Acid SCHEMBL2086627 0.75 TDP1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0143379-B1 METHOD FOR THE PREPARATION OF BETA-HYDROXY-ETHYL-(1,2,4-TRIAZOLE) DERIVATIVES BAYER AG (DE) 1988-03-30 EP claimed
US-4719307-A REARRANGEMENT BAYER AKTIENGESELLSCHAFT (DE) 1988-01-12 US claimed
US-4639527-A REARRANGEMENT BAYER AKTIENGESELLSCHAFT (DE) 1987-01-27 US claimed
US-4626594-A Process for the preparation of beta-hydroxyethyl-(1,2,4-triazole) derivatives BAYER AKTIENGESELLSCHAFT (DE) 1986-12-02 US claimed
JP-60132968-A None JP disclosed
JP-60136571-A None JP disclosed
EP-4374877-A2 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-29 EP disclosed
EP-3928779-B1 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. CHUGAI PHARMACEUTICAL CO LTD (JP) 2024-03-06 EP disclosed
CN-116997449-A Enhanced wood preservative containing zinc and boron 阿萨达有限责任公司 2023-11-03 CN disclosed
EP-3928779-A1 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. Chugai Seiyaku Kabushiki Kaisha (JP) 2021-12-29 EP disclosed
EP-3192511-B1 PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR CHUGAI PHARMACEUTICAL CO LTD (JP) 2021-07-14 EP disclosed
CN-107072993-B Pharmaceutical containing sodium-dependent phosphate transporter inhibitor 中外制药株式会社 2021-02-12 CN disclosed
US-4639527-A REARRANGEMENT BAYER AKTIENGESELLSCHAFT (DE) 1987-01-27 US disclosed
US-4626594-A Process for the preparation of beta-hydroxyethyl-(1,2,4-triazole) derivatives BAYER AKTIENGESELLSCHAFT (DE) 1986-12-02 US disclosed
US-4626594-A Process for the preparation of beta-hydroxyethyl-(1,2,4-triazole) derivatives BAYER AKTIENGESELLSCHAFT (DE) 1986-12-02 US disclosed
US-4626594-A Process for the preparation of beta-hydroxyethyl-(1,2,4-triazole) derivatives BAYER AKTIENGESELLSCHAFT (DE) 1986-12-02 US disclosed
JP-S60136571-A MANUFACTURE OF BETA-HYDROXYETHYL-(1,2,4-TRIAZOLE) DERIVATIVE BAYER AG 1985-07-20 JP disclosed
JP-S60132968-A MANUFACTURE OF BETA-HYDROXYETHYL-(1,2,4-TRIAZOLE) DERIVATIVE BAYER AG 1985-07-16 JP disclosed
EP-0143379-A1 Method for the preparation of beta-hydroxy-ethyl-(1,2,4-triazole) derivatives BAYER AG (DE) 1985-06-05 EP disclosed
EP-0143384-A2 Process for the preparation of beta-hydroxyethyl-1,2,4-triazole derivatives BAYER AG (DE) 1985-06-05 EP disclosed